Administrative Core
行政核心
基本信息
- 批准号:10378613
- 负责人:
- 金额:$ 119.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdvertisementsAdvisory CommitteesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnimal WelfareBiological MarkersClinicalClinical ResearchClinical TrialsCollaborationsCommunicationCommunitiesDataData SetDevelopmentDiseaseEnsureEventFaculty RecruitmentFinancial SupportFutureGoalsHeterogeneityHuman ResourcesLeadLeadershipMarshalMassachusettsMentorsMissionMonitorNerve DegenerationParticipantPoliciesProcessResearchResearch PersonnelResearch PriorityResearch Project GrantsResourcesRoleRotationSamplingScienceSeriesStrategic PlanningStressSumTechnologyTimeTissuesTrainingTraining SupportUnited States National Institutes of HealthWorkeducation researchfight againsthuman subjectmeetingsneuroimagingnew growthnew technologyprogramsrecruitsymposiumtooltransmission process
项目摘要
Massachusetts Alzheimer’s Disease Research Center: Administrative Core
The Administrative Core of the Massachusetts Alzheimer’s Disease Research Center (MADRC) leads the
Center’s efforts to contribute to our understanding of Alzheimer’s disease and Alzheimer’s disease related
disorders (AD/ADRD). The Administrative Core sets the strategic priorities and outlines the tactics: We
created the strategic plan for this application, with a focus on two closely related topics: heterogeneity of
dementing illness and accelerating a path towards a cure. We coordinate efforts of the various components of
the Center with each other, and coordinate planning for optimal utilization of resources within the Center and
by leveraging institutional capabilities. We also act as an interface for the Center to optimize connections with
the lay public, with institutional stake holders, and with national efforts. We take an active role in future
planning, faculty recruitment and retention, and training of future leaders. The Administrative core coordinates
interactions to develop trans-ADRC and other outside research projects. We oversee the research and grant
administrative processes, including human subjects, animal welfare (if needed by a Developmental Project),
scientific integrity, data and sample sharing, and financial policy requirements. We ensure timely and complete
communication with NACC, timely and complete submission of samples to NCRAD, and continued
participation in NIA summits and similar national forums.
The Core is assisted and advised by an Executive Committee, composed of Core leaders and institutional
leaders, and by a series of special purpose committees, including Developmental Projects, Clinical Studies
Committee (which also oversees clinical trials interactions), Tissue and Biofluid distribution committee, Data
Committee, ORE and the Community Advisory Board committee, and a REC committee. We are also advised
by and assisted by an External Advisory Committee that will provide input on all aspects of Center activities.
Importantly, we recruit, select, and monitor, and mentor the recipients of the exciting new Developmental
Projects program, to which we are devoting maximal allowed resources. The Chair of the External Advisory
Committee also chairs the selection committee; we hope to use this program to further enhance the growth of
new science and new investigators, as another tool to build the future of our program. In sum, the
Administrative Core provides leadership and support for both the broad efforts of the Center and support for
the day-to-day activities that allow the Center have a maximal impact in our fight against AD/ADRD.
马萨诸塞州阿尔茨海默病研究中心:行政核心
马萨诸塞州阿尔茨海默病研究中心 (MADRC) 的行政核心领导着
中心致力于帮助我们了解阿尔茨海默病以及阿尔茨海默病相关疾病
行政核心设定战略重点并概述策略:我们
为此应用程序制定了战略计划,重点关注两个密切相关的主题:
我们协调各方面的努力,以减轻疾病的负担并加速治愈疾病的进程。
中心相互优化,协调规划中心内部资源利用,
通过利用机构能力,我们还充当该中心的接口,以优化与该中心的联系。
未来,我们将在公众、机构利益相关者以及国家努力下发挥积极作用。
行政核心协调规划、教师招聘和保留以及未来领导者的培训。
我们负责监督研究和资助,以开发跨 ADRC 和其他外部研究项目。
行政流程,包括人类受试者、动物福利(如果发展项目需要)、
我们确保科学诚信、数据和样本共享以及财务政策要求的及时和完整。
与NACC沟通,及时完整地向NCRAD提交样品,并持续
参加 NIA 峰会和类似的国家论坛。
核心由执行委员会提供协助和建议,执行委员会由核心领导人和机构组成
领导者以及一系列特殊目的委员会,包括发展项目、临床研究
委员会(还监督临床试验相互作用)、组织和生物流体分配委员会、数据
委员会、ORE 和社区咨询委员会以及 REC 委员会。
由外部咨询委员会负责并协助该委员会,该委员会将为中心活动的各个方面提供意见。
重要的是,我们招募、选择、监控和指导令人兴奋的新发展计划的接受者
项目计划,我们投入最大允许的资源。
委员会还担任评选委员会主席;我们希望利用这个计划进一步促进成长
新的科学和新的研究人员,作为构建我们计划的未来的另一个工具。
行政核心为中心的广泛努力提供领导和支持,并为
使中心能够在我们对抗 AD/ADRD 的斗争中产生最大影响的日常活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADLEY T. HYMAN其他文献
BRADLEY T. HYMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADLEY T. HYMAN', 18)}}的其他基金
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease
发现和开发用于治疗阿尔茨海默病的 apoE4 校正剂
- 批准号:
10901029 - 财政年份:2023
- 资助金额:
$ 119.21万 - 项目类别:
MGH Diseases of Aging Pathway Via Stimulating Access to Research in Residency (MGH DAP StARR)
通过刺激住院医师研究参与 MGH 衰老途径疾病 (MGH DAP StARR)
- 批准号:
10592226 - 财政年份:2023
- 资助金额:
$ 119.21万 - 项目类别:
Multi-omic Brain Cell Atlas of Alzheimer's Disease Progression
阿尔茨海默病进展的多组学脑细胞图谱
- 批准号:
10461533 - 财政年份:2021
- 资助金额:
$ 119.21万 - 项目类别:
LRP1-tau interactions and Alzheimer Disease
LRP1-tau 相互作用与阿尔茨海默病
- 批准号:
10274154 - 财政年份:2021
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10332246 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
9914193 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10378606 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10620661 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center P30 Diversity Supplement Gaona
马萨诸塞州阿尔茨海默病研究中心 P30 多样性补充剂高纳
- 批准号:
10522320 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10511260 - 财政年份:2019
- 资助金额:
$ 119.21万 - 项目类别:
相似海外基金
Washington Obstetric-Fetal Pharmacology Research Unit
华盛顿产胎儿药理学研究单位
- 批准号:
7695403 - 财政年份:2004
- 资助金额:
$ 119.21万 - 项目类别: